IBB — iShares Biotechnology ETF price, holdings and performance

iShares Biotechnology ETF

iShares Biotechnology ETF (NASDAQ: IBB) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
190.15
+4.24+2.28%
OverviewShort InterestFilings
IBBiShares Biotechnology ETF·NASDAQ
190.15+2.28%
TA
Loading chart...
Screen all →
VXUS+1.68%$86.45VUG+2.31%$89.09VTV+1.30%$223.87VO+1.36%$82.89VB+1.97%$305.55VGT+4.35%$120.15VWO+1.68%$60.05SPCK+0.14%$22.12
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y40.83%Total Holdings248Perf Week-0.19%
SponsorISharesETF TypeTagssectorReturn% 3Y14.04%AUM$9.39BPerf Month-2.64%
Fund FamilyBond TypeTags-Return% 5Y2.93%NAV/shPerf Quarter11.75%
Index-Average MaturityTags-Return% 10Y52W High199.05 -4.47%Perf Half Y9.19%
Index WeightingCommodity TypeTags-Return% SI52W Low130.25 45.99%Perf YTD12.67%
Active/PassiveQuant TypeTags-Flows% 1M2.02%Volatility2.02% 1.85%Perf Year42.93%
Dividend TTM0.41 (0.22%)ESG TypeTags-Flows% 3M9.43%ATR (14)3.68Perf 3Y46.43%
Dividend Ex-DateJun 15, 2026Dividend TypeSector/ThemeFlows% YTD12.57%RSI (14)55.65Perf 5Y17.20%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.69Perf 10Y102.09%
Expense0.44%Growth/ValueSMA200.27%Flows% 3YRel Volume0.72Prev Close185.91
Inverse/LeveragedMarket CapSMA504.62%Flows% 5YAvg Volume1.56MPrice190.15
IPO DateFeb 05, 2001Option/ShortYes / YesSMA20010.57%52W Range %87%Volume1,123,656Change2.28%
Assets Under Management
02.50B5.00B7.50B10.00B'24MarMayJulSepNov'25MarMayJulSepNov'26MarMayJul
● Assets Under Management
Latest News
Jul-30-26
Jul-30-2612:28AM
Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collideinvezz.com
Jul-29-26
Jul-29-2611:58PM
Health Care's Clean Bill Of BreadthSeekingAlpha
Jul-28-26
Jul-28-2603:14AM
Cetera Investment Advisers Buys 10,994 Shares of iShares Biotechnology ETF $IBBdefenseworld.net
Jul-27-26
Jul-27-2607:25AM
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It247wallst.com
Jul-25-26
Jul-25-2608:25AM
Healthcare Systems' Liquidity ChallengeSeekingAlpha
Jul-23-26
Jul-23-2603:15PM
Playing The Biotech Breakout With Insidersseekingalpha.com
07:49AM
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?fool.com
Jul-22-26
Jul-22-2612:32AM
Kospi jumps 6% as Asia's battered semiconductor trade reboundsinvezz.com
Jul-21-26
Jul-21-2603:01PM
Buying Biotech's Policy Discount With XBI And IBB: Most 'Feared' Nation Policy, Less-Than-Feared DamageSeekingAlpha
Jul-18-26
Jul-18-2601:03PM
AI Bubble Risks Make Dividend Stocks Attractive Againseekingalpha.com
Jul-14-26
Jul-14-2603:06PM
SELLAS Life Sciences: Strong Buy-Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught UpSeekingAlpha
Jul-12-26
Jul-12-2603:30PM
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?fool.com
Jul-10-26
Jul-10-2606:41AM
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?fool.com
Jul-07-26
Jul-07-2601:20PM
Chip Rout Drags Nasdaq 100 Lower, Oil Climbs: Stock Market TodayBenzinga
Jul-06-26
Jul-06-2602:04PM
3 Healthcare ETFs to Own in a Choppy Stock Marketbarrons.com
Fund

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR